Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Ventas Inc. Common Stock (VTR) Price & Performance

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade
Ventas Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Ventas Inc. Common Stock — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.69 (market cap $58.74B), while Ventas Inc. Common Stock trades at $82.85 (market cap $41.94B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is the larger of the two by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and Ventas Inc. Common Stock for 0 Days on average.

TAKVTR
Market Cap
$58.74B$41.94B
Volume
3,110,9944,588,793
Sector
HealthReal Estate
52-Week High
$19.05$100.53
52-Week Low
$13.23$67.45
Typical Hold Time
0 Days0 Days
Enterprise Value
$86.65B$54.66B
Dividend Yield
3.33%2.54%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TAK
100% Buy0% Sell
Avg holding period · 0 Days
VTR
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →

About Ventas Inc. Common Stock

Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.

Read more on VTR →